As a result, overexpression or blockade of Tim-3 signaling in mice with experimental autoimmune encephalomyelitis (EAE) inhibited or increased MHC-II expression respectively and finally altered clinical outcomes. This evidence concerns the gene HAVCR2 and experimental autoimmune encephalomyelitis.